menu
    • menu

    Company profile for Diaccurate

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Endocrine-resistant metastatic breast tumor, glioblastoma, refractory acute myeloid leukemia, … to beat incurable cancers, Diaccurate explores the new frontiers of oncology in search of daring novel therapeutic approaches able to save lives. Now in the clinic, the French biotech is currently developing 3 proprietary therapeutics with novel mechanisms of action across several development programs: - DIACC3010, an optimized S...
    Endocrine-resistant metastatic breast tumor, glioblastoma, refractory acute myeloid leukemia, … to beat incurable cancers, Diaccurate explores the new frontiers of oncology in search of daring novel therapeutic approaches able to save lives. Now in the clinic, the French biotech is currently developing 3 proprietary therapeutics with novel mechanisms of action across several development programs: - DIACC3010, an optimized S6 Kinase inhibitor, highly selective oral antitumoral agent that crosses the blood-brain barrier

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    DiaccurateFrance Flag
    Country
    Country
    France
    Address
    Address
    104 Bd de Sébastopol, 75003 Paris
    Telephone
    Telephone
    33 (0)1 78 96 41 70
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.diaccurate.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/diaccurate/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/diaccuratetx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Diaccurate Announces the Appointment of Scott Filosi as CEO
    Diaccurate Announces the Appointment of Scott Filosi as CEO

    06 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/06/2774098/0/en/Diaccurate-Announces-the-Appointment-of-Scott-Filosi-as-CEO-and-Corporate-Name-Change-to-Evexta-Bio.html

    GLOBENEWSWIRE
    06 Nov 2023
    Share Share
    Diaccurate Announces Updated Data on its Novel PAM Pathway Inhibitor DIACC3010
    Diaccurate Announces Updated Data on its Novel PAM Pathway Inhibitor DIACC3010

    06 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/06/2642549/0/en/Diaccurate-Announces-Updated-Data-on-its-Novel-PAM-Pathway-Inhibitor-DIACC3010-in-Patients-with-ER-HER2-Metastatic-Breast-Cancer-to-be-Presented-at-AACR-2023.html

    GLOBENEWSWIRE
    06 Apr 2023
    Share Share
    Diaccurate receives support from Bpifrance to conduct its DIACC2020 Program
    Diaccurate receives support from Bpifrance to conduct its DIACC2020 Program

    05 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/01/05/2583363/0/en/Diaccurate-receives-support-from-Bpifrance-to-conduct-its-DIACC2020-Program-on-the-development-of-new-payloads-for-antibody-drug-conjugates-ADCs.html

    GLOBENEWSWIRE
    05 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search